E225-0313 Screening compound: 2-(2-butoxyphenyl)-N-cyclohexyl-5-ethyl-6-methyl-4-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide

E225-0313 Screening compound: 2-(2-butoxyphenyl)-N-cyclohexyl-5-ethyl-6-methyl-4-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide
E225-0313 Screening compound: 2-(2-butoxyphenyl)-N-cyclohexyl-5-ethyl-6-methyl-4-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E225-0313
2-(2-butoxyphenyl)-N-cyclohexyl-5-ethyl-6-methyl-4-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E225-0313

Molecular Formula

C26H36N4O3 (C26 H36 N4 O3)

Compound Name

2-(2-butoxyphenyl)-N-cyclohexyl-5-ethyl-6-methyl-4-oxo-4H,5H,6H,7H-pyrazolo[1,5-a]pyrazine-6-carboxamide

IUPAC name

2-(2-butoxyphenyl)-N-cyclohexyl-5-ethyl-6-methyl-4-oxo-4H5H6H7H-pyrazolo[15-a]pyrazine-6-carboxamide

SMILES

CCCCOc(cccc1)c1-c1nn(CC(C)(C(NC2CCCCC2)=O)N(CC)C2=O)c2c1

InChI

InChI=1S/C26H36N4O3/c1-4-6-16-33-23-15-11-10-14-20(23)21-17-22-24(31)29(5-2)26(3,18-30(22)28-21)25(32)27-19-12-8-7-9-13-19/h10-11,14-15,17,19H,4-9,12-13,16,18H2,1-3H3,(H,27,32)/t26-/m0/s1

InChI Key

RFULWNKKBWXZLQ-SANMLTNESA-N

MDL Number (MFCD)

MFCD27598558

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

452.6

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

7

Partition Coefficient, logP

5.028

Distribution Coefficient, logD

5.028

Water Solubility, LogSw

-4.64

Polar Surface Area

60.699

Acid Dissociation Constant (pKa)

14.81

Base Dissociation Constant (pKb)

3.12

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

57.70

E225-0313 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cyclic Ugi PPI Library (9586 compounds)

Protein-Protein Interaction Library (218420 compounds)

Developmental Pathway (Hh/Wnt) Set (2238 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Mimetics
Therapeutical areas:
  • Cancer
  • Digestive system
  • Female
  • Hemic and lymphatic
  • Skin
Targets:
  • Others

References: we are preparing a list of scientific research reports with E225-0313 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E225-0313?
Check Price and Availability of E225-0313, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E225-0313 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E225-0313
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E225-0313
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E225-0313 available by request